Ogawa, L.; Morinishi, C.; Multani, A.; Gaynor, P.; Beaird, O.E.; Pham, C.; Schaenman, J.M.
Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses 2024, 16, 1889.
https://doi.org/10.3390/v16121889
AMA Style
Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM.
Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses. 2024; 16(12):1889.
https://doi.org/10.3390/v16121889
Chicago/Turabian Style
Ogawa, Lauren, Chelsea Morinishi, Ashrit Multani, Pryce Gaynor, Omer E. Beaird, Christine Pham, and Joanna M. Schaenman.
2024. "Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients" Viruses 16, no. 12: 1889.
https://doi.org/10.3390/v16121889
APA Style
Ogawa, L., Morinishi, C., Multani, A., Gaynor, P., Beaird, O. E., Pham, C., & Schaenman, J. M.
(2024). Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Viruses, 16(12), 1889.
https://doi.org/10.3390/v16121889
